Company
Headquarters: Kwun Tong, Hong Kong
Employees: 1,723
CEO: Mr. Kwong Yip Sum
HK$1.31 Billion
HKD as of July 1, 2024
US$167.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Jacobson Pharma Corporation Limited, through its subsidiaries, manufactures, markets, and sells generic drugs and branded healthcare products in Hong Kong, China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including respiratory, cardiovascular, central nervous system, gastrointestinal, scar treatment, oral anti-diabetics, anti-infective, arsenic trioxide oral solution, dihydrocodeine tablet, perindopril tablet, atomoxetine capsule, rosuvastatin tablet, hydroxychloroquine tablet, desloratadine tablet, metronidazole gel, and ofloxacin eye drops. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines, such as Po Chai pills, Ho Chai Kung Tji Thung San, Tong Tai Chung Woodlok oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling oil, Contractubex, Doan's Ointment, and Col-gan tablet. In addition, it trades in medical supplies. Jacobson Pharma Corporation Limited sells its products to hospitals and clinics, and registered pharmacies, as well as to doctors in private and retail outlets, and trading companies. The company was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Jacobson Pharma Corporation Limited is a subsidiary of Kingshill Development Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Jacobson Pharma Corp Ltd has the following listings and related stock indices.
Stock: HKEX: 2633 wb_incandescent